ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

AIDS Malignancy Consortium (AMC) - International Protocol Development Support

Completed
Institution
Icahn School of Medicine at Mount Sinai, NY
Principal investigator
Joseph A. Sparano
Funding
$78K
Duration
2024–2025
Open portfolio

Moonbase score

Still being scored

Abstract

Abstract/Lay Summary The AIDS Malignancy Consortium (AMC) was established in 1995 and has been at the forefront of the clinical evaluation of interventions for the treatment and prevention of malignancies in people living with the human immunodeficiency virus (PLWH). The consortium includes 10 international trial sites located in 6 countries in sub-Saharan Africa (including 6 sites in South Africa, Kenya, Zimbabwe, Uganda, and Malawi) and Latin America (including 4 sites in Mexico, Brazil, and Argentina). The supplement to the AMC grant (2UM1CA121947) will support convening an expert group of scientific reviewers to provide peer review of approximately 2-4 AMC clinical trials annually that will involve patient accrual from the 10 AMC international sites.

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTEUM1malignancyinternationalconsortiumsitesafricazimbabweaidsamc

Questions for Icahn School of Medicine at Mount Sinai

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.